SK285349B6 - Liečivo na prevenciu a/alebo liečenie karcinómu pŕs, ktoré obsahuje inhibítor steroidnej aromatázy - Google Patents

Liečivo na prevenciu a/alebo liečenie karcinómu pŕs, ktoré obsahuje inhibítor steroidnej aromatázy Download PDF

Info

Publication number
SK285349B6
SK285349B6 SK1342-2000A SK13422000A SK285349B6 SK 285349 B6 SK285349 B6 SK 285349B6 SK 13422000 A SK13422000 A SK 13422000A SK 285349 B6 SK285349 B6 SK 285349B6
Authority
SK
Slovakia
Prior art keywords
weight
medicament
drug
use according
estrogen
Prior art date
Application number
SK1342-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK13422000A3 (sk
Inventor
Alfred Schmidt
Heinrich Wieland
Original Assignee
Medical Discoveries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8231611&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK285349(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medical Discoveries, Inc. filed Critical Medical Discoveries, Inc.
Publication of SK13422000A3 publication Critical patent/SK13422000A3/sk
Publication of SK285349B6 publication Critical patent/SK285349B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
SK1342-2000A 1998-03-18 1999-03-03 Liečivo na prevenciu a/alebo liečenie karcinómu pŕs, ktoré obsahuje inhibítor steroidnej aromatázy SK285349B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98104949A EP0943333A1 (fr) 1998-03-18 1998-03-18 Médicament pour la prévention et/ou le traitement du cancer du sein contenant un inhibiteur de la synthèse d'estrogènes
PCT/EP1999/001374 WO1999047143A1 (fr) 1998-03-18 1999-03-03 Medicament contenant un inhibiteur steroidien de l'aromatase pour la prophylaxie et/ou le traitement du carcinome du sein

Publications (2)

Publication Number Publication Date
SK13422000A3 SK13422000A3 (sk) 2001-05-10
SK285349B6 true SK285349B6 (sk) 2006-11-03

Family

ID=8231611

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1342-2000A SK285349B6 (sk) 1998-03-18 1999-03-03 Liečivo na prevenciu a/alebo liečenie karcinómu pŕs, ktoré obsahuje inhibítor steroidnej aromatázy

Country Status (19)

Country Link
EP (2) EP0943333A1 (fr)
JP (1) JP4920822B2 (fr)
KR (1) KR100778803B1 (fr)
CN (1) CN1168448C (fr)
AT (1) ATE230995T1 (fr)
AU (1) AU751040B2 (fr)
BR (1) BR9908885A (fr)
CA (1) CA2324077C (fr)
CZ (1) CZ292643B6 (fr)
DE (1) DE59904042D1 (fr)
DK (1) DK1063998T3 (fr)
ES (1) ES2190201T3 (fr)
HU (1) HU226105B1 (fr)
ID (1) ID26965A (fr)
IL (1) IL138292A (fr)
PL (1) PL343100A1 (fr)
RU (1) RU2225206C2 (fr)
SK (1) SK285349B6 (fr)
WO (1) WO1999047143A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10042411A1 (de) * 2000-08-30 2002-03-28 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Abgabe von Exemestan
DE10054294A1 (de) * 2000-11-02 2002-05-16 Heinrich Wieland Topische Behandlung bei der Mastalgie
JP4524296B2 (ja) * 2007-03-30 2010-08-11 生化学工業株式会社 発毛促進剤
DE102007032468A1 (de) 2007-07-10 2009-01-15 Brätter, Christian, Dr. Transdermale Therapeutische Systeme, welche den Wirkstoff Anastrozol enthalten
US11850451B2 (en) 2011-01-31 2023-12-26 Lucolas-M.D. Ltd. Cosmetic compositions and methods for improving skin conditions
KR20140040690A (ko) * 2011-01-31 2014-04-03 루콜라스-엠.디. 리미티드 미용학적 용도
TR201816243T4 (tr) 2011-01-31 2018-11-21 Lucolas M D Ltd Aromataz inhibitörlerinin ve antioksidanların kombinasyonları.
EP3666276A1 (fr) * 2018-12-14 2020-06-17 dcic Biopharmaceutical Limited Médicament contre la tumeur positive du récepteur d'oestrogene beta (erbeta)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235893A (en) * 1978-05-08 1980-11-25 Brodie Angela M Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis
DE3322285A1 (de) * 1983-06-18 1984-12-20 Schering AG, 1000 Berlin und 4709 Bergkamen 1-alkyl-androsta-1,4-dien-3,17-dione, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
FR2558373B1 (fr) * 1984-01-20 1987-07-03 Mauvais Jarvis Pierre Medicament antioestrogene a base de 4-hydroxytamoxifene pour administration percutanee
JPS6345294A (ja) * 1986-04-07 1988-02-26 Shionogi & Co Ltd アロマタ−ゼ阻害ステロイド誘導体
EP0310542B1 (fr) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Composés antigestagéniques et anti-oestrogéniques pour le traitement des tumeurs dépendant des hormones
FR2656310B1 (fr) * 1989-12-22 1992-05-07 Roussel Uclaf Nouveaux produits sterouides comportant en position 10, un radical thioethyle substitue, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
DE4039559A1 (de) * 1990-12-07 1992-06-11 Schering Ag Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
GB9212833D0 (en) * 1992-06-17 1992-07-29 Glaxo Group Ltd Chemical compounds
JP2810236B2 (ja) * 1993-03-16 1998-10-15 フアイザー・インコーポレイテツド ナフタレン誘導体
JPH07215992A (ja) * 1993-12-07 1995-08-15 Teikoku Hormone Mfg Co Ltd ６−又は７−置換アンドロスタ−１，４−ジエン誘導体
JPH10508828A (ja) * 1994-09-14 1998-09-02 セントラル シェフィールド ユニバーシティ ホスピタルズ エヌエイチエス トラスト 毛髪成長の制御
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
ES2156361T5 (es) * 1996-03-29 2012-12-26 Keyvest Gmbh Cosmético o bien composición cosmética para el alisado y la tersura de la piel en el caso de tejido adiposo afectado, en especial en el caso de la "celulitis"
EP0930876B2 (fr) * 1996-07-22 2010-07-07 Renovo Limited Utilisation de promoteurs de l'activite oestrogenique pour l' accéleration de la quérison des blessures de la peau

Also Published As

Publication number Publication date
KR100778803B1 (ko) 2007-11-27
JP2002506823A (ja) 2002-03-05
SK13422000A3 (sk) 2001-05-10
IL138292A (en) 2005-08-31
ID26965A (id) 2001-02-22
CA2324077C (fr) 2008-07-29
EP0943333A1 (fr) 1999-09-22
WO1999047143A1 (fr) 1999-09-23
KR20010034603A (ko) 2001-04-25
DE59904042D1 (de) 2003-02-20
JP4920822B2 (ja) 2012-04-18
ATE230995T1 (de) 2003-02-15
CZ292643B6 (cs) 2003-11-12
RU2225206C2 (ru) 2004-03-10
EP1063998B1 (fr) 2003-01-15
CN1168448C (zh) 2004-09-29
BR9908885A (pt) 2000-11-21
ES2190201T3 (es) 2003-07-16
CN1301165A (zh) 2001-06-27
HU226105B1 (en) 2008-04-28
AU3143499A (en) 1999-10-11
CA2324077A1 (fr) 1999-09-23
PL343100A1 (en) 2001-07-30
EP1063998A1 (fr) 2001-01-03
IL138292A0 (en) 2001-10-31
DK1063998T3 (da) 2003-05-12
AU751040B2 (en) 2002-08-08
CZ20003256A3 (cs) 2001-04-11
HUP0101005A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
US6884795B2 (en) Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol
KR101403895B1 (ko) 유방암 및 관련 질병들에 대한 약제
SK286664B6 (sk) Použitie dehydroepiandrosterónu na prípravu liečiva na prevenciu alebo liečenie zníženého libida alebo osteoporózy
AU2008323199B2 (en) C-19 steroids for therapeutic uses
ES2263682T3 (es) Tratamiento topico de la mastalgia.
SK285349B6 (sk) Liečivo na prevenciu a/alebo liečenie karcinómu pŕs, ktoré obsahuje inhibítor steroidnej aromatázy
US8343948B2 (en) Medicament for preventing and/or treating mammary carcinoma, containing a steroidal aromatase inhibitor
Mor et al. Cutaneous complications of hormonal replacement therapy
Rasmusson et al. Therapeutic control of androgen action
MXPA00009126A (en) Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor